{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T10:52:00Z","timestamp":1769597520515,"version":"3.49.0"},"reference-count":274,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2006,2,1]],"date-time":"2006-02-01T00:00:00Z","timestamp":1138752000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,2,1]],"date-time":"2006-02-01T00:00:00Z","timestamp":1138752000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2006,2]]},"DOI":"10.1016\/j.jaad.2004.11.060","type":"journal-article","created":{"date-parts":[[2006,1,27]],"date-time":"2006-01-27T10:34:01Z","timestamp":1138358041000},"page":"189-206","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":118,"title":["Cutaneous malignancy and human immunodeficiency virus disease"],"prefix":"10.1016","volume":"54","author":[{"given":"Karl","family":"Wilkins","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryan","family":"Turner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacqueline C.","family":"Dolev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip E.","family":"LeBoit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy G.","family":"Berger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toby A.","family":"Maurer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2004.11.060_bib1","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1056\/NEJM199803263381301","article-title":"Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators","volume":"338","author":"Palella","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2004.11.060_bib2","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1016\/S0140-6736(98)03201-2","article-title":"Changing patterns of mortality across Europe in patients infected with HIV-1. EuroSIDA Study Group","volume":"352","author":"Mocroft","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.jaad.2004.11.060_bib3","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/S0140-6736(03)14570-9","article-title":"Determinants of survival following HIV-1 seroconversion after the introduction of HAART","volume":"362","author":"Porter","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.jaad.2004.11.060_bib4","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1038\/bjc.1998.610","article-title":"Risk of cancer other than Kaposi's sarcoma and non-Hodgkin's lymphoma in persons with AIDS in Italy. Cancer and AIDS Registry Linkage Study","volume":"78","author":"Franceschi","year":"1998","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jaad.2004.11.060_bib5","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1002\/(SICI)1097-4652(200005)183:2<284::AID-JCP15>3.0.CO;2-C","article-title":"New dimensions in cancer biology and therapy","volume":"183","author":"Giordano","year":"2000","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.jaad.2004.11.060_bib6","doi-asserted-by":"crossref","first-page":"323","DOI":"10.3109\/07853899809029932","article-title":"AIDS-related malignancies","volume":"30","author":"Smith","year":"1998","journal-title":"Ann Med"},{"key":"10.1016\/j.jaad.2004.11.060_bib7","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1093\/jnci\/92.22.1823","article-title":"Highly active antiretroviral therapy and incidence of cancer in human immunodeficiency virus\u2013infected adults","volume":"92","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.jaad.2004.11.060_bib8","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1097\/00000372-200104000-00003","article-title":"Molluscum contagiosum: histologic patterns and associated lesions. A study of 578 cases","volume":"23","author":"Cribier","year":"2001","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.jaad.2004.11.060_bib9","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1053\/rr.2000.5269","article-title":"Cancers in renal transplant recipients","volume":"7","author":"Penn","year":"2000","journal-title":"Adv Ren Replace Ther"},{"key":"10.1016\/j.jaad.2004.11.060_bib10","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S0190-9622(94)70253-5","article-title":"Idiopathic CD4+ T-cell lymphocytopenia with verrucae, basal cell carcinomas, and chronic tinea corporis infection","volume":"31","author":"Ohashi","year":"1994","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2004.11.060_bib11","doi-asserted-by":"crossref","first-page":"822","DOI":"10.2169\/internalmedicine.36.822","article-title":"Idiopathic CD4+ T-lymphocytopenia with Bowen's disease","volume":"36","author":"Hayashi","year":"1997","journal-title":"Intern Med"},{"key":"10.1016\/j.jaad.2004.11.060_bib12","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/0304-3835(86)90055-8","article-title":"Lymphocytopenia in high cancer risk population: evidence in automobile pattern makers","volume":"30","author":"Bang","year":"1986","journal-title":"Cancer Lett"},{"key":"10.1016\/j.jaad.2004.11.060_bib13","doi-asserted-by":"crossref","first-page":"177","DOI":"10.3109\/10428199609067597","article-title":"B non-Hodgkin's lymphoma in a haemophilia patient with idiopathic CD4+ T-lymphocytopenia","volume":"21","author":"Paolini","year":"1996","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.jaad.2004.11.060_bib14","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/00126334-200011010-00001","article-title":"The dominant source of CD4+ and CD8+ T-cell activation in HIV infection is antigenic stimulation","volume":"25","author":"Cohen Stuart","year":"2000","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.jaad.2004.11.060_bib15","first-page":"121","article-title":"Cd38 expression on Cd8+ T cells in human immunodeficiency virus 1\u2013positive adults treated with HAART","volume":"47","author":"Beran","year":"2003","journal-title":"Acta Virol"},{"key":"10.1016\/j.jaad.2004.11.060_bib16","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1086\/314660","article-title":"Shorter survival in advanced human immunodeficiency virus type 1 infection is more closely associated with T lymphocyte activation than with plasma virus burden or virus chemokine coreceptor usage","volume":"179","author":"Giorgi","year":"1999","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jaad.2004.11.060_bib17","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/nm0402-319","article-title":"CD4+ T-cell depletion in HIV infection: are we closer to understanding the cause?","volume":"8","author":"Grossman","year":"2002","journal-title":"Nat Med"},{"key":"10.1016\/j.jaad.2004.11.060_bib18","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1086\/374786","article-title":"T cell activation is associated with lower CD4+ T cell gains in human immunodeficiency virus\u2013infected patients with sustained viral suppression during antiretroviral therapy","volume":"187","author":"Hunt","year":"2003","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jaad.2004.11.060_bib19","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/S0889-8588(03)00047-9","article-title":"Immune reconstitution in HIV infection and its relationship to cancer","volume":"17","author":"Robertson","year":"2003","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1016\/j.jaad.2004.11.060_bib20","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S1521-6616(03)00214-6","article-title":"Non-Hodgkin's B cell lymphoma in persons with acquired immunodeficiency syndrome is associated with increased serum levels of IL10, or the IL10 promoter-592 C\/C genotype","volume":"109","author":"Breen","year":"2003","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jaad.2004.11.060_bib21","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0065-230X(02)84008-8","article-title":"Chronic immune activation and inflammation in the pathogenesis of AIDS and cancer","volume":"84","author":"Dalgleish","year":"2002","journal-title":"Adv Cancer Res"},{"key":"10.1016\/j.jaad.2004.11.060_bib22","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.jaad.2003.11.075","article-title":"The role of interleukin 10 in the pathogenesis and potential treatment of skin diseases","volume":"50","author":"Weiss","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2004.11.060_bib23","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0378-1097(03)00067-3","article-title":"HIV tat, its targets and the control of viral gene expression","volume":"220","author":"Brigati","year":"2003","journal-title":"FEMS Microbiol Lett"},{"key":"10.1016\/j.jaad.2004.11.060_bib24","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1128\/CMR.15.2.310-326.2002","article-title":"Angiogenic effects of extracellular human immunodeficiency virus type 1 Tat protein and its role in the pathogenesis of AIDS-associated Kaposi's sarcoma","volume":"15","author":"Barillari","year":"2002","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.jaad.2004.11.060_bib25","doi-asserted-by":"crossref","first-page":"41","DOI":"10.2174\/1570162033352057","article-title":"In vivo analysis of Nef function","volume":"1","author":"Wei","year":"2003","journal-title":"Curr HIV Res"},{"key":"10.1016\/j.jaad.2004.11.060_bib26","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/35004038","article-title":"HIV-1 Nef protein binds to the cellular protein PACS-1 to downregulate class I major histocompatibility complexes","volume":"2","author":"Piguet","year":"2000","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.jaad.2004.11.060_bib27","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1046\/j.1523-1747.2002.19610.x","article-title":"Increased CCR4 expression in cutaneous T cell lymphoma","volume":"119","author":"Ferenczi","year":"2002","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2004.11.060_bib28","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/S0889-8588(03)00046-7","article-title":"Hodgkin's disease in HIV","volume":"17","author":"Spina","year":"2003","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1016\/j.jaad.2004.11.060_bib29","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/sj.bjc.6601017","article-title":"Risk of cancer in persons with AIDS in Italy, 1985-1998","volume":"89","author":"Dal Maso","year":"2003","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jaad.2004.11.060_bib30","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1097\/00002030-200205240-00009","article-title":"Rates of non-AIDS-defining cancers in people with HIV infection before and after AIDS diagnosis","volume":"16","author":"Grulich","year":"2002","journal-title":"AIDS"},{"key":"10.1016\/j.jaad.2004.11.060_bib31","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.1200\/JCO.1995.13.10.2540","article-title":"Incidence of human immunodeficiency virus\u2013related and nonrelated malignancies in a large cohort of homosexual men","volume":"13","author":"Lyter","year":"1995","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jaad.2004.11.060_bib32","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1097\/00002030-200301030-00011","article-title":"Improved survival in HIV-related Hodgkin's lymphoma since the introduction of highly active antiretroviral therapy","volume":"17","author":"Gerard","year":"2003","journal-title":"AIDS"},{"key":"10.1016\/j.jaad.2004.11.060_bib33","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1182\/blood-2002-03-0989","article-title":"Stanford V regimen and concomitant HAART in 59 patients with Hodgkin disease and HIV infection","volume":"100","author":"Spina","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.jaad.2004.11.060_bib34","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1093\/annonc\/mdg152","article-title":"High international prognostic score predicts a worse outcome for patients with Hodgkin's disease and HIV infection: results of a prospective study with Stanford V regimen","volume":"14","author":"Spina","year":"2003","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jaad.2004.11.060_bib35","first-page":"657","article-title":"AIDS malignancies in the era of highly active antiretroviral therapy","volume":"16","author":"Gates","year":"2002","journal-title":"Oncology (Huntingt)"},{"key":"10.1016\/j.jaad.2004.11.060_bib36","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1016\/S0140-6736(97)09028-4","article-title":"Spectrum of AIDS-associated malignant disorders","volume":"351","author":"Goedert","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.jaad.2004.11.060_bib37","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1182\/blood.V81.7.1889.1889","article-title":"Acquired immunodeficiency syndrome\u2013associated non-Hodgkin's lymphomas and other malignancies in patients with hemophilia","volume":"81","author":"Ragni","year":"1993","journal-title":"Blood"},{"key":"10.1016\/j.jaad.2004.11.060_bib38","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/S1470-2045(03)00983-5","article-title":"Epidemiology of non-Hodgkin lymphomas and other haemolymphopoietic neoplasms in people with AIDS","volume":"4","author":"Dal Maso","year":"2003","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jaad.2004.11.060_bib39","doi-asserted-by":"crossref","first-page":"3406","DOI":"10.1182\/blood.V98.12.3406","article-title":"Non-Hodgkin lymphoma in HIV-infected patients in the era of highly active antiretroviral therapy","volume":"98","author":"Kirk","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.jaad.2004.11.060_bib40","doi-asserted-by":"crossref","first-page":"86","DOI":"10.3816\/CLM.2003.n.016","article-title":"Acquired immunodeficiency syndrome\u2013related lymphoma in the era of highly active antiretroviral therapy","volume":"4","author":"Thirlwell","year":"2003","journal-title":"Clin Lymphoma"},{"key":"10.1016\/j.jaad.2004.11.060_bib41","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1001\/jama.285.14.1880","article-title":"HIV-associated non-Hodgkin lymphoma: incidence, presentation, and prognosis","volume":"285","author":"Little","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.jaad.2004.11.060_bib42","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1097\/00002030-200008180-00001","article-title":"Epidemiological, biological and clinical features of HIV-related lymphomas in the era of highly active antiretroviral therapy","volume":"14","author":"Tirelli","year":"2000","journal-title":"AIDS"},{"key":"10.1016\/j.jaad.2004.11.060_bib43","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1001\/jama.1989.03420050069041","article-title":"AIDS-associated non-Hodgkin's lymphoma in San Francisco","volume":"261","author":"Kaplan","year":"1989","journal-title":"JAMA"},{"key":"10.1016\/j.jaad.2004.11.060_bib44","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1097\/00002030-200307040-00013","article-title":"Response to highly active antiretroviral therapy strongly predicts outcome in patients with AIDS-related lymphoma","volume":"17","author":"Hoffmann","year":"2003","journal-title":"AIDS"},{"key":"10.1016\/j.jaad.2004.11.060_bib45","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1080\/1042819021000006402","article-title":"Favorable impact of virological response to highly active antiretroviral therapy on survival in patients with AIDS-related lymphoma","volume":"43","author":"Navarro","year":"2002","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.jaad.2004.11.060_bib46","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1097\/00126334-200303010-00017","article-title":"Improved outcome of AIDS-related lymphoma in patients with virologic response to highly active antiretroviral therapy","volume":"32","author":"Navarro","year":"2003","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.jaad.2004.11.060_bib47","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1097\/00002030-200209270-00020","article-title":"Prognostic impact of highly active antiretroviral therapy in HIV-related Hodgkin's disease","volume":"16","author":"Ribera","year":"2002","journal-title":"AIDS"},{"key":"10.1016\/j.jaad.2004.11.060_bib48","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1097\/00126334-200208150-00003","article-title":"Systemic non-Hodgkin lymphoma in HIV-infected patients with effective suppression of HIV replication: persistent occurrence but improved survival","volume":"30","author":"Gerard","year":"2002","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.jaad.2004.11.060_bib49","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1002\/(SICI)1096-8652(199803)57:3<266::AID-AJH25>3.0.CO;2-7","article-title":"Complete remission of a primary effusion lymphoma with antiretroviral therapy","volume":"57","author":"Oksenhendler","year":"1998","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jaad.2004.11.060_bib50","first-page":"236","article-title":"Spontaneous regression of HIV-associated T-cell non-Hodgkin's lymphoma with highly active antiretroviral therapy","volume":"5","author":"Fatkenheuer","year":"2000","journal-title":"Eur J Med Res"},{"key":"10.1016\/j.jaad.2004.11.060_bib51","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1097\/00000478-199910000-00005","article-title":"The spectrum of cutaneous lymphomas in HIV infection: a study of 21 cases","volume":"23","author":"Beylot-Barry","year":"1999","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.jaad.2004.11.060_bib52","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1097\/00000478-199504000-00002","article-title":"Neutrophil-rich, Ki-1-positive anaplastic large-cell malignant lymphoma","volume":"19","author":"Mann","year":"1995","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.jaad.2004.11.060_bib53","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1093\/ajcp\/114.3.478","article-title":"Neutrophil-rich anaplastic large cell lymphoma of T-cell lineage. A report of two cases arising in HIV-positive patients","volume":"114","author":"Jhala","year":"2000","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.jaad.2004.11.060_bib54","doi-asserted-by":"crossref","first-page":"3078","DOI":"10.1002\/1097-0142(19931115)72:10<3078::AID-CNCR2820721033>3.0.CO;2-F","article-title":"CD30 (Ki-1) positive anaplastic large cell lymphomas in individuals infected with the human immunodeficiency virus","volume":"72","author":"Chadburn","year":"1993","journal-title":"Cancer"},{"key":"10.1016\/j.jaad.2004.11.060_bib55","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1097\/00043426-199811000-00009","article-title":"CD30-positive anaplastic large cell lymphoma (ALCL) of T-cell lineage in a 14-month-old infant with perinatally acquired HIV-1 infection","volume":"20","author":"Funkhouser","year":"1998","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.jaad.2004.11.060_bib56","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1001\/archderm.1995.01690230059010","article-title":"Cutaneous presentations of lymphoma in human immunodeficiency virus disease. Predominance of T cell lineage","volume":"131","author":"Kerschmann","year":"1995","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2004.11.060_bib57","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1093\/ajcp\/105.4.440","article-title":"CD30-positive cutaneous large cell lymphomas. A comparative study of clinicopathologic and molecular features of 16 cases","volume":"105","author":"Macgrogan","year":"1996","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.jaad.2004.11.060_bib58","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/S0936-6555(05)80864-7","article-title":"Isolated cutaneous relapse in Hodgkin's disease: a case report and review of the literature","volume":"5","author":"Davies","year":"1993","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1016\/j.jaad.2004.11.060_bib59","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1046\/j.1365-2133.1999.02936.x","article-title":"Human herpesvirus type 8 and Epstein-Barr virus\u2013associated cutaneous lymphoma taking anaplastic large cell morphology in a man with HIV infection","volume":"141","author":"Nakamura","year":"1999","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2004.11.060_bib60","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/0190-9622(93)70140-O","article-title":"Spectrum of primary cutaneous CD30 (Ki-1)\u2013positive lymphoproliferative disorders. A proposal for classification and guidelines for management and treatment","volume":"28","author":"Willemze","year":"1993","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2004.11.060_bib61","series-title":"Basic mechanisms of physiologic and aberrant lymphoproliferation in the skin","first-page":"265","article-title":"Primary cutaneous CD30 (Ki-1) positive large cell lymphomas: definition and differential diagnostic aspects","author":"Willemze","year":"1994"},{"key":"10.1016\/j.jaad.2004.11.060_bib62","first-page":"354","article-title":"EORTC classification for primary cutaneous lymphomas: a proposal from the Cutaneous Lymphoma Study Group of the European Organization for Research and Treatment of Cancer","volume":"90","author":"Willemze","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.jaad.2004.11.060_bib63","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1046\/j.1365-2133.2003.05248.x","article-title":"Pyogenic lymphoma of the skin: a peculiar variant of primary cutaneous neutrophil-rich CD30+ anaplastic large-cell lymphoma. Clinicopathological study of four cases and review of the literature","volume":"148","author":"Burg","year":"2003","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2004.11.060_bib64","doi-asserted-by":"crossref","first-page":"3653","DOI":"10.1182\/blood.V95.12.3653","article-title":"Primary and secondary cutaneous CD30(+) lymphoproliferative disorders: a report from the Dutch Cutaneous Lymphoma Group on the long-term follow-up data of 219 patients and guidelines for diagnosis and treatment","volume":"95","author":"Bekkenk","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.jaad.2004.11.060_bib65","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1002\/1097-0142(19930315)71:6<2097::AID-CNCR2820710626>3.0.CO;2-7","article-title":"Primary cutaneous CD30-positive large cell lymphoma: definition of a new type of cutaneous lymphoma with a favorable prognosis. A European Multicenter Study of 47 patients","volume":"71","author":"Beljaards","year":"1993","journal-title":"Cancer"},{"key":"10.1016\/j.jaad.2004.11.060_bib66","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/S0190-9622(94)70175-X","article-title":"The use of methotrexate for treatment of psoriasis in patients with HIV infection","volume":"31","author":"Maurer","year":"1994","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2004.11.060_bib67","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1086\/375067","article-title":"Comparison of 2 regimens that include interferon-alpha-2a plus ribavirin for treatment of chronic hepatitis C in human immunodeficiency virus-coinfected patients","volume":"36","author":"Neau","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jaad.2004.11.060_bib68","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1089\/107999001753238114","article-title":"Low-dose IFN-alpha monotherapy in treatment-naive individuals with HIV-1 infection: evidence of potent suppression of viral replication","volume":"21","author":"Hatzakis","year":"2001","journal-title":"J Interferon Cytokine Res"},{"key":"10.1016\/j.jaad.2004.11.060_bib69","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1056\/NEJM199607043350118","article-title":"Massive infiltration of the skin by HIV-specific cytotoxic CD8+ T cells","volume":"335","author":"Bachelez","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2004.11.060_bib70","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1046\/j.1365-4362.1999.00417.x","article-title":"Atypical cutaneous lymphoproliferative disorder in patients with HIV infection","volume":"38","author":"Friedler","year":"1999","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2004.11.060_bib71","doi-asserted-by":"crossref","first-page":"738","DOI":"10.7326\/0003-4819-110-9-738","article-title":"The pseudo-Sezary syndrome with CD8 phenotype in a patient with the acquired immunodeficiency syndrome (AIDS)","volume":"110","author":"Janier","year":"1989","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jaad.2004.11.060_bib72","first-page":"307","article-title":"[Pigmented erythroderma in AIDS. 5 cases]","volume":"123","author":"Picard-Dahan","year":"1996","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.jaad.2004.11.060_bib73","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/00000372-199502000-00006","article-title":"Mycosis fungoideslike T-cell cutaneous lymphoid infiltrates in patients with HIV infection","volume":"17","author":"Zhang","year":"1995","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.jaad.2004.11.060_bib74","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1089\/aid.1994.10.1173","article-title":"Cutaneous disease resembling mycosis fungoides in HIV-infected patients whose skin and blood cells also harbor proviral HTLV type I","volume":"10","author":"Zucker-Franklin","year":"1994","journal-title":"AIDS Res Hum Retroviruses"},{"key":"10.1016\/j.jaad.2004.11.060_bib75","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1001\/archderm.1995.01690180119029","article-title":"Sezary's syndrome and human immunodeficiency virus infection","volume":"131","author":"Berger","year":"1995","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2004.11.060_bib76","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1056\/NEJM198909283211318","article-title":"Homme rouge and the acquired immunodeficiency syndrome","volume":"321","author":"Parker","year":"1989","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2004.11.060_bib77","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/0002-9343(91)90132-H","article-title":"Syndrome of severe skin disease, eosinophilia, and dermatopathic lymphadenopathy in patients with HTLV-II complicating human immunodeficiency virus infection","volume":"91","author":"Kaplan","year":"1991","journal-title":"Am J Med"},{"key":"10.1016\/j.jaad.2004.11.060_bib78","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/S0190-9622(99)70007-1","article-title":"Cutaneous CD8 T cell infiltrates in advanced HIV infection","volume":"41","author":"Guitart","year":"1999","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2004.11.060_bib79","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/0190-9622(93)70201-4","article-title":"Cutaneous T-cell lymphoma associated with HIV infection","volume":"29","author":"Burns","year":"1993","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2004.11.060_bib80","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1001\/archderm.1991.01680060063005","article-title":"Cutaneous T-cell lymphoma in patients with human immunodeficiency virus infection","volume":"127","author":"Crane","year":"1991","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2004.11.060_bib81","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1002\/1097-0142(19900915)66:6<1130::AID-CNCR2820660609>3.0.CO;2-0","article-title":"Cutaneous T-cell lymphoma in a patient infected with human immunodeficiency virus type 1. Use of radiation therapy","volume":"66","author":"Goldstein","year":"1990","journal-title":"Cancer"},{"key":"10.1016\/j.jaad.2004.11.060_bib82","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1097\/00000478-198802000-00002","article-title":"Granulomatous variants of cutaneous T-cell lymphoma. The histopathology of granulomatous mycosis fungoides and granulomatous slack skin","volume":"12","author":"LeBoit","year":"1988","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.jaad.2004.11.060_bib83","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1097\/00000372-198910000-00007","article-title":"Atypical cutaneous lymphoproliferative disorder resembling mycosis fungoides in AIDS. Report of a case with concurrent Kaposi's sarcoma","volume":"11","author":"Longacre","year":"1989","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.jaad.2004.11.060_bib84","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1080\/000155599750011426","article-title":"Cutaneous T-cell lymphoma and human immunodeficiency virus infection: 2 cases and a review of the literature","volume":"79","author":"Munoz-Perez","year":"1999","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jaad.2004.11.060_bib85","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1056\/NEJM200003303421304","article-title":"HTLV-II-associated cutaneous T-cell lymphoma in a patient with HIV-1 infection","volume":"342","author":"Poiesz","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2004.11.060_bib86","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/S0190-9622(97)80016-3","article-title":"Spontaneous regression of granulomatous mycosis fungoides in an HIV positive patient","volume":"37","author":"Sorrells","year":"1997","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2004.11.060_bib87","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1001\/archderm.1991.01680060094011","article-title":"Cutaneous T-cell lymphoma associated with the acquired immunodeficiency syndrome","volume":"127","author":"Nahass","year":"1991","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2004.11.060_bib88","doi-asserted-by":"crossref","first-page":"4059","DOI":"10.1182\/blood-2003-04-1044","article-title":"Profound loss of T cell receptor repertoire complexity in cutaneous T cell lymphoma","volume":"102","author":"Yawalker","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.jaad.2004.11.060_bib89","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1172\/JCI1450","article-title":"Oligoclonal expansion of HIV-specific cytotoxic CD8 T lymphocytes in the skin of HIV-1-infected patients with cutaneous pseudolymphoma","volume":"101","author":"Bachelez","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaad.2004.11.060_bib90","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1002\/1097-0142(19880301)61:5<947::AID-CNCR2820610515>3.0.CO;2-G","article-title":"Peripheral T-cell lymphoma in a patient with acquired immune deficiency syndrome","volume":"61","author":"Nasr","year":"1988","journal-title":"Cancer"},{"key":"10.1016\/j.jaad.2004.11.060_bib91","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1111\/j.1365-4362.1991.tb03483.x","article-title":"Lymphoid proliferation and lymphoma associated with human retroviruses (HTLV and HIV)","volume":"30","author":"Jimbow","year":"1991","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2004.11.060_bib92","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1056\/NEJM200007273430416","article-title":"HIV-1 and an HTLV-II-associated cutaneous T-cell lymphoma","volume":"343","author":"Guitart","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2004.11.060_bib93","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S0889-8588(03)00038-8","article-title":"Non-AIDS-defining cancer in HIV-infected people","volume":"17","author":"Cooley","year":"2003","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1016\/j.jaad.2004.11.060_bib94","first-page":"581","article-title":"[Malignant melanoma and HIV infection]","volume":"64","author":"Rasokat","year":"1989","journal-title":"Z Hautkr"},{"key":"10.1016\/j.jaad.2004.11.060_bib95","first-page":"446","article-title":"Five cases of melanoma in HIV positive patients","volume":"11","author":"Calista","year":"2001","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.jaad.2004.11.060_bib96","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1002\/1097-0339(200103)24:3<186::AID-DC1038>3.0.CO;2-W","article-title":"Fine-needle aspiration diagnosis of unusual cutaneous neoplasms of the scalp in HIV-infected patients: a report of two cases and review of the literature","volume":"24","author":"Solomon","year":"2001","journal-title":"Diagn Cytopathol"},{"key":"10.1016\/j.jaad.2004.11.060_bib97","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1111\/j.1365-2133.1992.tb11828.x","article-title":"Cutaneous malignant melanoma and human immunodeficiency virus (HIV) infection: a report of three cases","volume":"126","author":"McGregor","year":"1992","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2004.11.060_bib98","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/00008390-199804000-00015","article-title":"Malignant melanoma associated with human immunodeficiency virus infection: a case report and review of the literature","volume":"8","author":"Massi","year":"1998","journal-title":"Melanoma Res"},{"key":"10.1016\/j.jaad.2004.11.060_bib99","first-page":"510","article-title":"Fine needle aspiration of solid tumors in HIV-positive patients","volume":"43","author":"Gattuso","year":"1999","journal-title":"Acta Cytol"},{"key":"10.1016\/j.jaad.2004.11.060_bib100","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1097\/00000637-199609000-00007","article-title":"Human immunodeficiency virus infection and subsequent melanoma","volume":"37","author":"Kind","year":"1996","journal-title":"Ann Plast Surg"},{"key":"10.1016\/j.jaad.2004.11.060_bib101","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1001\/archderm.1987.01660310031009","article-title":"A case of malignant melanoma in AIDS-related complex","volume":"123","author":"Krause","year":"1987","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2004.11.060_bib102","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/S0190-9622(89)80196-3","article-title":"Malignant melanoma in a man seropositive for the human immunodeficiency virus","volume":"20","author":"Rivers","year":"1989","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2004.11.060_bib103","doi-asserted-by":"crossref","first-page":"217","DOI":"10.3109\/07357909809039770","article-title":"Malignant melanoma in an HIV-infected man: a case report and literature review","volume":"16","author":"Aboulafia","year":"1998","journal-title":"Cancer Invest"},{"key":"10.1016\/j.jaad.2004.11.060_bib104","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/S0190-9622(08)80607-X","article-title":"Multiple primary malignant melanomas in an HIV-positive man","volume":"24","author":"van Ginkel","year":"1991","journal-title":"J Am Acad Dermatol"},{"issue":"suppl","key":"10.1016\/j.jaad.2004.11.060_bib105","doi-asserted-by":"crossref","first-page":"S172","DOI":"10.1067\/mjd.2002.107966","article-title":"Multiple nevoid malignant melanomas in a patient with AIDS: the role of proliferating cell nuclear antigen in the diagnosis","volume":"47","author":"Pereira","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2004.11.060_bib106","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/0190-9622(93)70202-5","article-title":"Cutaneous neoplasms in a military population of HIV-1-positive patients. Military Medical Consortium for the Advancement of Retroviral Research","volume":"29","author":"Smith","year":"1993","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2004.11.060_bib107","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/S0190-9622(89)70068-2","article-title":"Malignant melanoma associated with human immunodeficiency virus infection in three homosexual men","volume":"20","author":"Tindall","year":"1989","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2004.11.060_bib108","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1001\/archderm.138.6.765","article-title":"Altered clinical course of malignant melanoma in HIV-positive patients","volume":"138","author":"Rodrigues","year":"2002","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2004.11.060_bib109","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1056\/NEJMra041245","article-title":"Management of cutaneous melanoma","volume":"351","author":"Tsao","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2004.11.060_bib110","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1067\/mjd.2001.117044","article-title":"Guidelines of care for primary cutaneous melanoma","volume":"45","author":"Sober","year":"2001","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2004.11.060_bib111","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/00002030-200401020-00009","article-title":"Pegylated interferon alpha 2b and ribavirin in HIV\/hepatitis C virus-co-infected non-responders and relapsers to IFN-based therapy","volume":"18","author":"Myers","year":"2004","journal-title":"AIDS"},{"key":"10.1016\/j.jaad.2004.11.060_bib112","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1002\/1521-4141(200105)31:5<1351::AID-IMMU1351>3.0.CO;2-9","article-title":"Interleukin-2 induced immune effects in human immunodeficiency virus-infected patients receiving intermittent interleukin-2 immunotherapy","volume":"31","author":"Kovacs","year":"2001","journal-title":"Eur J Immunol"},{"issue":"Suppl 2","key":"10.1016\/j.jaad.2004.11.060_bib113","doi-asserted-by":"crossref","first-page":"S115","DOI":"10.1086\/340201","article-title":"Immune therapy: non-highly active antiretroviral therapy management of human immunodeficiency virus-infected patients","volume":"185","author":"Mitsuyasu","year":"2002","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jaad.2004.11.060_bib114","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/S0190-9622(97)70033-1","article-title":"Chronic varicella zoster infection mimicking a basal cell carcinoma in an AIDS patient","volume":"36","author":"Tsao","year":"1997","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2004.11.060_bib115","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1111\/j.1524-4725.1995.tb00544.x","article-title":"Disseminated cutaneous Cryptococcus clinically mimicking basal cell carcinoma","volume":"21","author":"Murakawa","year":"1995","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.jaad.2004.11.060_bib116","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1001\/archderm.1997.03890410031004","article-title":"Cutaneous squamous cell carcinoma in human immunodeficiency virus-infected patients. A study of epidemiologic risk factors, human papillomavirus, and p53 expression","volume":"133","author":"Maurer","year":"1997","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2004.11.060_bib117","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1001\/archderm.1992.01680150053003","article-title":"Nonmelanoma skin cancers and infection with the human immunodeficiency virus","volume":"128","author":"Lobo","year":"1992","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2004.11.060_bib118","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1111\/j.1524-4725.1995.tb00516.x","article-title":"Histologic patterns of basal cell carcinoma based upon patient immunostatus","volume":"21","author":"Oram","year":"1995","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.jaad.2004.11.060_bib119","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1001\/jama.1987.03390030070024","article-title":"Metastatic basal cell carcinoma in acquired immunodeficiency syndrome-related complex","volume":"257","author":"Sitz","year":"1987","journal-title":"JAMA"},{"key":"10.1016\/j.jaad.2004.11.060_bib120","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1034\/j.1600-0560.2000.027006316.x","article-title":"Multiple infundibulocystic basal cell carcinomas in association with human immunodeficiency virus","volume":"27","author":"Kagen","year":"2000","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.jaad.2004.11.060_bib121","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1111\/j.1524-4725.1997.tb00687.x","article-title":"The development of a Marjolin's cancer in a human immunodeficiency virus-positive hemophilic man and review of the literature","volume":"23","author":"Rahimizadeh","year":"1997","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.jaad.2004.11.060_bib122","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1111\/j.1600-0560.1997.tb01326.x","article-title":"The Muir-Torre syndrome in a black patient with AIDS: histopathology and molecular genetic studies","volume":"24","author":"Warschaw","year":"1997","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.jaad.2004.11.060_bib123","first-page":"268","article-title":"[Transformation of multiple basaliomas to squamous cell carcinomas in an HIV patient with Gorlin-Goltz syndrome]","volume":"46","author":"Wolfer","year":"1995","journal-title":"Hautarzt"},{"key":"10.1016\/j.jaad.2004.11.060_bib124","first-page":"891","article-title":"[Oncological complications after renal transplantation]","volume":"20","author":"Alamartine","year":"1991","journal-title":"Presse Med"},{"key":"10.1016\/j.jaad.2004.11.060_bib125","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1365-2133.1991.tb03286.x","article-title":"Epidermodysplasia verruciformis\u2013associated papillomavirus infection complicating human immunodeficiency virus disease","volume":"124","author":"Berger","year":"1991","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2004.11.060_bib126","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1067\/mjd.2003.184","article-title":"Human papillomavirus\u2013associated digital squamous cell carcinoma: literature review and report of 21 new cases","volume":"48","author":"Alam","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2004.11.060_bib127","first-page":"984","article-title":"Rapidly enlarging growth of the proximal nail fold","volume":"29","author":"High","year":"2003","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.jaad.2004.11.060_bib128","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1001\/archderm.1997.03890410031004","article-title":"Cutaneous squamous cell carcinoma in human immunodeficiency virus\u2013infected patients. A study of epidemiologic risk factors, human papillomavirus, and p53 expression","volume":"133","author":"Maurer","year":"1997","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2004.11.060_bib129","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1136\/jcp.52.4.249","article-title":"Human papillomavirus and the development of non-melanoma skin cancer","volume":"52","author":"Harwood","year":"1999","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.jaad.2004.11.060_bib130","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1046\/j.1365-2249.2003.02159.x","article-title":"The role of p53 in the immunobiology of cutaneous squamous cell carcinoma","volume":"132","author":"Black","year":"2003","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jaad.2004.11.060_bib131","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/S0046-8177(03)00352-6","article-title":"Human papillomavirus infection in actinic keratosis and bowen's disease: comparative study with expression of cell-cycle regulatory proteins p21(Waf1\/Cip1), p53, PCNA, Ki-67, and Bcl-2 in positive and negative lesions","volume":"34","author":"Mitsuishi","year":"2003","journal-title":"Hum Pathol"},{"key":"10.1016\/j.jaad.2004.11.060_bib132","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1001\/archderm.138.6.758","article-title":"Aggressive squamous cell carcinomas in persons infected with the human immunodeficiency virus","volume":"138","author":"Nguyen","year":"2002","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2004.11.060_bib133","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1001\/archderm.138.6.758","article-title":"Aggressive squamous cell carcinomas in persons infected with the human immunodeficiency virus","volume":"138","author":"Nguyen","year":"2002","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2004.11.060_bib134","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1056\/NEJM198710153171601","article-title":"Sexual practices, sexually transmitted diseases, and the incidence of anal cancer","volume":"317","author":"Daling","year":"1987","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2004.11.060_bib135","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1023\/A:1008216430806","article-title":"The use of cardiac biopsy to demonstrate reduced cardiotoxicity in AIDS Kaposi's sarcoma patients treated with pegylated liposomal doxorubicin","volume":"9","author":"Berry","year":"1998","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jaad.2004.11.060_bib136","first-page":"638","article-title":"Incidence of anal cytological abnormalities in a cohort of human immunodeficiency virus\u2013infected women","volume":"12","author":"Durante","year":"2003","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.jaad.2004.11.060_bib137","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1093\/jnci\/92.18.1500","article-title":"Human papillomavirus\u2013associated cancers in patients with human immunodeficiency virus infection and acquired immunodeficiency syndrome","volume":"92","author":"Frisch","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.jaad.2004.11.060_bib138","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1097\/00042560-199804010-00005","article-title":"Anal squamous intraepithelial lesions in HIV-positive and HIV-negative homosexual and bisexual men: prevalence and risk factors","volume":"17","author":"Palefsky","year":"1998","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"key":"10.1016\/j.jaad.2004.11.060_bib139","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1086\/344057","article-title":"Natural history and clinical management of anal human papillomavirus disease in men and women infected with human immunodeficiency virus","volume":"35","author":"Chin-Hong","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jaad.2004.11.060_bib140","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1086\/514194","article-title":"Prevalence and risk factors for human papillomavirus infection of the anal canal in human immunodeficiency virus (HIV)-positive and HIV-negative homosexual men","volume":"177","author":"Palefsky","year":"1998","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jaad.2004.11.060_bib141","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1086\/318071","article-title":"Prevalence and risk factors for anal human papillomavirus infection in human immunodeficiency virus (HIV)-positive and high-risk HIV-negative women","volume":"183","author":"Palefsky","year":"2001","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jaad.2004.11.060_bib142","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1097\/00002030-199805000-00011","article-title":"High incidence of anal high-grade squamous intra-epithelial lesions among HIV-positive and HIV-negative homosexual and bisexual men","volume":"12","author":"Palefsky","year":"1998","journal-title":"AIDS"},{"key":"10.1016\/j.jaad.2004.11.060_bib143","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1093\/infdis\/162.2.358","article-title":"Anal human papillomavirus infection among human immunodeficiency virus\u2013seropositive and \u2013seronegative men","volume":"162","author":"Kiviat","year":"1990","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jaad.2004.11.060_bib144","first-page":"205","article-title":"Anal and cervical human papillomavirus infection and risk of anal and cervical epithelial abnormalities in human immunodeficiency virus\u2013infected women","volume":"83","author":"Williams","year":"1994","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jaad.2004.11.060_bib145","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1097\/00002030-199805000-00011","article-title":"High incidence of anal high-grade squamous intra-epithelial lesions among HIV-positive and HIV-negative homosexual and bisexual men","volume":"12","author":"Palefsky","year":"1998","journal-title":"AIDS"},{"key":"10.1016\/j.jaad.2004.11.060_bib146","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/S0002-9378(11)80029-3","article-title":"The increased frequency of cervical dysplasia-neoplasia in women infected with the human immunodeficiency virus is related to the degree of immunosuppression","volume":"164","author":"Schafer","year":"1991","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jaad.2004.11.060_bib147","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1136\/sti.74.5.349","article-title":"Tissue specific HPV expression and downregulation of local immune responses in condylomas from HIV seropositive individuals","volume":"74","author":"Arany","year":"1998","journal-title":"Sex Transm Infect"},{"key":"10.1016\/j.jaad.2004.11.060_bib148","first-page":"1281","article-title":"p53, WAF1\/CIP1 and mdm2 expression in skin lesions associated with human papillomavirus and human immunodeficiency virus","volume":"17","author":"Arany","year":"1997","journal-title":"Anticancer Res"},{"issue":"Pt 11","key":"10.1016\/j.jaad.2004.11.060_bib149","doi-asserted-by":"crossref","first-page":"2937","DOI":"10.1099\/0022-1317-80-11-2937","article-title":"Human immunodeficiency virus infection in vitro activates naturally integrated human papillomavirus type 18 and induces synthesis of the L1 capsid protein","volume":"80","author":"Dolei","year":"1999","journal-title":"J Gen Virol"},{"key":"10.1016\/j.jaad.2004.11.060_bib150","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1097\/00042560-200112150-00003","article-title":"Effect of highly active antiretroviral therapy on the natural history of anal squamous intraepithelial lesions and anal human papillomavirus infection","volume":"28","author":"Palefsky","year":"2001","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.jaad.2004.11.060_bib151","first-page":"471","article-title":"Anal squamous intraepithelial lesions in human immunodeficiency virus\u2013positive men and women","volume":"27","author":"Palefsky","year":"2000","journal-title":"Semin Oncol"},{"key":"10.1016\/j.jaad.2004.11.060_bib152","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1097\/00002030-200301240-00028","article-title":"Lack of response of anal intra-epithelial neoplasia to highly active antiretroviral therapy","volume":"17","author":"Fox","year":"2003","journal-title":"AIDS"},{"issue":"Suppl 1","key":"10.1016\/j.jaad.2004.11.060_bib153","first-page":"S42","article-title":"Anal squamous intraepithelial lesions: relation to HIV and human papillomavirus infection","volume":"21","author":"Palefsky","year":"1999","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.jaad.2004.11.060_bib154","first-page":"471","article-title":"Anal squamous intraepithelial lesions in human immunodeficiency virus\u2013positive men and women","volume":"27","author":"Palefsky","year":"2000","journal-title":"Semin Oncol"},{"key":"10.1016\/j.jaad.2004.11.060_bib155","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1097\/00042560-199704150-00004","article-title":"Anal cytology as a screening tool for anal squamous intraepithelial lesions","volume":"14","author":"Palefsky","year":"1997","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"key":"10.1016\/j.jaad.2004.11.060_bib156","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1086\/344057","article-title":"Natural history and clinical management of anal human papillomavirus disease in men and women infected with human immunodeficiency virus","volume":"35","author":"Chin-Hong","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jaad.2004.11.060_bib157","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1001\/jama.281.19.1822","article-title":"The clinical effectiveness and cost-effectiveness of screening for anal squamous intraepithelial lesions in homosexual and bisexual HIV-positive men","volume":"281","author":"Goldie","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.jaad.2004.11.060_bib158","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1056\/NEJMoa020586","article-title":"A controlled trial of a human papillomavirus type 16 vaccine","volume":"347","author":"Koutsky","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2004.11.060_bib159","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1038\/bjc.1996.635","article-title":"Survival of classic Kaposi's sarcoma and risk of second cancer","volume":"74","author":"Franceschi","year":"1996","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jaad.2004.11.060_bib160","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1002\/ijc.10274","article-title":"Effect of highly active antiretroviral therapy on survival among HIV-infected men with Kaposi sarcoma or non-Hodgkin lymphoma","volume":"98","author":"Tam","year":"2002","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jaad.2004.11.060_bib161","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1016\/S0959-8049(01)00106-X","article-title":"Impact of HAART on the clinical management of AIDS-related cancers","volume":"37","author":"Tirelli","year":"2001","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jaad.2004.11.060_bib162","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1097\/00126334-200007010-00013","article-title":"Incidence and trends in Kaposi's sarcoma in the era of effective antiretroviral therapy","volume":"24","author":"Jones","year":"2000","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.jaad.2004.11.060_bib163","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1097\/00000372-199708000-00010","article-title":"Bullous lesions in Kaposi's sarcoma: case report","volume":"19","author":"Borroni","year":"1997","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.jaad.2004.11.060_bib164","first-page":"285","article-title":"[Unifocal skin location of Kaposi's sarcoma, mimicking melanoma: the role of excisional biopsy for the timely identification of an unusual pathology with potential fatal prognosis]","volume":"22","author":"Russo","year":"2001","journal-title":"G Chir"},{"key":"10.1016\/j.jaad.2004.11.060_bib165","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/0140-6736(90)90001-L","article-title":"Kaposi's sarcoma among persons with AIDS: a sexually transmitted infection?","volume":"335","author":"Beral","year":"1990","journal-title":"Lancet"},{"key":"10.1016\/j.jaad.2004.11.060_bib166","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1126\/science.7997879","article-title":"Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma","volume":"266","author":"Chang","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.jaad.2004.11.060_bib167","doi-asserted-by":"crossref","first-page":"14862","DOI":"10.1073\/pnas.93.25.14862","article-title":"Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8)","volume":"93","author":"Russo","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jaad.2004.11.060_bib168","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1146\/annurev.med.52.1.453","article-title":"Kaposi's sarcoma-associated herpesvirus: a new DNA tumor virus","volume":"52","author":"Boshoff","year":"2001","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.jaad.2004.11.060_bib169","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1128\/jcm.34.10.2635-2638.1996","article-title":"Prevalence of human herpesvirus 8 DNA sequences in several patient populations","volume":"34","author":"Marchioli","year":"1996","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jaad.2004.11.060_bib170","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1097\/00002030-200009290-00006","article-title":"Relationship of human herpesvirus 8 peripheral blood virus load and Kaposi's sarcoma clinical stage","volume":"14","author":"Campbell","year":"2000","journal-title":"AIDS"},{"key":"10.1016\/j.jaad.2004.11.060_bib171","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1001\/archderm.1997.03890370031006","article-title":"Detection of human herpesvirus 8 and human T-cell lymphotropic virus type 1 sequences in Kaposi sarcoma","volume":"133","author":"Lebbe","year":"1997","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2004.11.060_bib172","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1159\/000051697","article-title":"Human herpesvirus 8 DNA in the skin and blood of patients with Mediterranean Kaposi's sarcoma: clinical correlations","volume":"203","author":"Boneschi","year":"2001","journal-title":"Dermatology"},{"key":"10.1016\/j.jaad.2004.11.060_bib173","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/S0140-6736(95)91619-9","article-title":"Detection of Kaposi sarcoma associated herpesvirus in peripheral blood of HIV-infected individuals and progression to Kaposi's sarcoma","volume":"346","author":"Whitby","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.jaad.2004.11.060_bib174","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1086\/514045","article-title":"Frequent detection of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) DNA in saliva of human immunodeficiency virus-infected men: clinical and immunologic correlates","volume":"176","author":"Koelle","year":"1997","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jaad.2004.11.060_bib175","doi-asserted-by":"crossref","first-page":"7083","DOI":"10.1128\/jvi.71.9.7083-7087.1997","article-title":"Transmissible Kaposi's sarcoma\u2013associated herpesvirus (human herpesvirus 8) in saliva of men with a history of Kaposi's sarcoma","volume":"71","author":"Vieira","year":"1997","journal-title":"J Virol"},{"key":"10.1016\/j.jaad.2004.11.060_bib176","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1056\/NEJM200011093431904","article-title":"Mucosal shedding of human herpesvirus 8 in men","volume":"343","author":"Pauk","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2004.11.060_bib177","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1086\/314514","article-title":"Detection of human herpesvirus 8 DNA sequences in tissues and bodily fluids","volume":"178","author":"LaDuca","year":"1998","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jaad.2004.11.060_bib178","doi-asserted-by":"crossref","first-page":"F15","DOI":"10.1097\/00002030-199702000-00001","article-title":"Detection of human herpesvirus 8 DNA in semen from HIV-infected individuals but not healthy semen donors","volume":"11","author":"Howard","year":"1997","journal-title":"AIDS"},{"key":"10.1016\/j.jaad.2004.11.060_bib179","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1182\/blood.V89.5.1686","article-title":"Is Kaposi's sarcoma\u2013associated herpesvirus ubiquitous in urogenital and prostate tissues?","volume":"89","author":"Tasaka","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.jaad.2004.11.060_bib180","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1128\/JCM.37.5.1298-1301.1999","article-title":"Multicenter comparison of PCR assays for detection of human herpesvirus 8 DNA in semen","volume":"37","author":"Pellett","year":"1999","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jaad.2004.11.060_bib181","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1046\/j.1365-2133.2000.03837.x","article-title":"Human herpesvirus-8 infection among heterosexual partners of patients with classical Kaposi's sarcoma","volume":"143","author":"Brambilla","year":"2000","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2004.11.060_bib182","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1002\/1097-0215(20000715)87:2<232::AID-IJC13>3.0.CO;2-T","article-title":"Seropositivity to human herpesvirus 8 in relation to sexual history and risk of sexually transmitted infections among women","volume":"87","author":"Tedeschi","year":"2000","journal-title":"Int J Cancer"},{"issue":"Suppl 1","key":"10.1016\/j.jaad.2004.11.060_bib183","first-page":"S38","article-title":"Kaposi's sarcoma in three HIV-1-infected cohorts","volume":"3","author":"Rabkin","year":"1990","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.jaad.2004.11.060_bib184","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1056\/NEJM199804023381403","article-title":"Sexual transmission and the natural history of human herpesvirus 8 infection","volume":"338","author":"Martin","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2004.11.060_bib185","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1086\/339605","article-title":"Correlates of prevalent and incident Kaposi's sarcoma\u2013associated herpesvirus infection in men who have sex with men","volume":"185","author":"Casper","year":"2002","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jaad.2004.11.060_bib186","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1093\/jnci\/91.17.1468","article-title":"Human herpesvirus 8 seropositivity and risk of Kaposi's sarcoma and other acquired immunodeficiency syndrome\u2013related diseases","volume":"91","author":"Rezza","year":"1999","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.jaad.2004.11.060_bib187","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1017\/S0950268800004726","article-title":"Serological and virological evidence of non-sexual transmission of human herpesvirus type 8 (HHV8)","volume":"125","author":"Vitale","year":"2000","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.jaad.2004.11.060_bib188","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1128\/JCM.37.4.1150-1153.1999","article-title":"Human herpesvirus 8 seroprevalence and evaluation of nonsexual transmission routes by detection of DNA in clinical specimens from human immunodeficiency virus\u2013seronegative patients from central and southern Italy, with and without Kaposi's sarcoma","volume":"37","author":"Cattani","year":"1999","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jaad.2004.11.060_bib189","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1046\/j.1469-0691.2003.00490.x","article-title":"Age-specific seroprevalence of human herpesvirus 8 in Mediterranean regions","volume":"9","author":"Cattani","year":"2003","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jaad.2004.11.060_bib190","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1001\/jama.280.1.31-a","article-title":"Serologic evidence for mother-to-child transmission of Kaposi sarcoma\u2013associated herpesvirus infection","volume":"280","author":"Bourboulia","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.jaad.2004.11.060_bib191","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1002\/(SICI)1097-0215(19980911)77:6<817::AID-IJC2>3.0.CO;2-X","article-title":"Prevalence and transmission of Kaposi's sarcoma\u2013associated herpesvirus (human herpesvirus 8) in Ugandan children and adolescents","volume":"77","author":"Mayama","year":"1998","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jaad.2004.11.060_bib192","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1056\/NEJM200004063421407","article-title":"Kaposi's sarcoma","volume":"342","author":"Antman","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2004.11.060_bib193","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1023\/A:1015678312153","article-title":"A seroprevalence study of human herpesvirus type 8 (HHV8) in eastern and central Africa and in the Mediterranean area","volume":"17","author":"Serraino","year":"2001","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.jaad.2004.11.060_bib194","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1093\/oxfordjournals.aje.a010196","article-title":"Invited commentary: determining specific sexual practices associated with human herpesvirus 8 transmission","volume":"151","author":"Martin","year":"2000","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.jaad.2004.11.060_bib195","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1086\/515340","article-title":"Antibodies to Kaposi's sarcoma\u2013associated herpesvirus (human herpesvirus 8) in patients with multiple myeloma","volume":"178","author":"Gao","year":"1998","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jaad.2004.11.060_bib196","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/S0140-6736(96)07560-5","article-title":"Prevalence of Kaposi's sarcoma associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigen","volume":"348","author":"Simpson","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.jaad.2004.11.060_bib197","first-page":"409","article-title":"Kaposi's sarcoma\u2013associated herpes virus and acquired immunodeficiency syndrome\u2013related malignancy","volume":"27","author":"Cannon","year":"2000","journal-title":"Semin Oncol"},{"key":"10.1016\/j.jaad.2004.11.060_bib198","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1038\/nm1295-1274","article-title":"Kaposi's sarcoma\u2013associated herpesvirus infects endothelial and spindle cells","volume":"1","author":"Boshoff","year":"1995","journal-title":"Nat Med"},{"key":"10.1016\/j.jaad.2004.11.060_bib199","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1016\/S0140-6736(86)91436-4","article-title":"Kaposi's sarcoma: a reversible hyperplasia","volume":"2","author":"Brooks","year":"1986","journal-title":"Lancet"},{"key":"10.1016\/j.jaad.2004.11.060_bib200","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1056\/NEJM198506203122513","article-title":"Spontaneously healing Kaposi's sarcoma in AIDS","volume":"312","author":"Janier","year":"1985","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2004.11.060_bib201","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1056\/NEJM199607253350403","article-title":"Seroconversion to antibodies against Kaposi's sarcoma\u2013associated herpesvirus\u2013related latent nuclear antigens before the development of Kaposi's sarcoma","volume":"335","author":"Gao","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2004.11.060_bib202","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1097\/00002030-199818000-00018","article-title":"Seroconversion for human herpesvirus 8 during HIV infection is highly predictive of Kaposi's sarcoma","volume":"12","author":"Renwick","year":"1998","journal-title":"AIDS"},{"key":"10.1016\/j.jaad.2004.11.060_bib203","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1098\/rstb.2000.0778","article-title":"Epidemiology and pathogenesis of Kaposi's sarcoma\u2013associated herpesvirus","volume":"356","author":"Boshoff","year":"2001","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"10.1016\/j.jaad.2004.11.060_bib204","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1182\/blood.V96.7.2562","article-title":"An IL6 promoter polymorphism is associated with a lifetime risk of development of Kaposi sarcoma in men infected with human immunodeficiency virus","volume":"96","author":"Foster","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.jaad.2004.11.060_bib205","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/S0140-6736(96)91388-4","article-title":"Classic Kaposi's sarcoma and volcanic soil in southern Italy","volume":"347","author":"Montella","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.jaad.2004.11.060_bib206","first-page":"439","article-title":"AIDS-related cancers in the era of highly active antiretroviral therapy","volume":"15","author":"Biggar","year":"2001","journal-title":"Oncology (Huntingt)"},{"key":"10.1016\/j.jaad.2004.11.060_bib207","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1097\/00002030-200005260-00010","article-title":"Long-term efficacy on Kaposi's sarcoma of highly active antiretroviral therapy in a cohort of HIV-positive patients. CISIH 92. Centre d'information et de soins de l'immunodeficience humaine","volume":"14","author":"Dupont","year":"2000","journal-title":"AIDS"},{"key":"10.1016\/j.jaad.2004.11.060_bib208","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1310\/VQXJ-41X6-GJA2-H6AG","article-title":"Effect of protease inhibitor\u2013based highly active antiretroviral therapy on survival in HIV-associated advanced Kaposi's sarcoma patients treated with chemotherapy","volume":"4","author":"Leitch","year":"2003","journal-title":"HIV Clin Trials"},{"key":"10.1016\/j.jaad.2004.11.060_bib209","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1097\/00002030-199710001-00007","article-title":"Reduction of Kaposi's sarcoma lesions following treatment of AIDS with ritonovir","volume":"11","author":"Conant","year":"1997","journal-title":"AIDS"},{"key":"10.1016\/j.jaad.2004.11.060_bib210","first-page":"261","article-title":"Regression of AIDS-related Kaposi's sarcoma following treatment with an HIV-1 protease inhibitor","volume":"11","author":"Murphy","year":"1997","journal-title":"AIDS"},{"key":"10.1016\/j.jaad.2004.11.060_bib211","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1097\/00002030-199910220-00014","article-title":"Highly active anti-retroviral therapy (HAART) prolongs time to treatment failure in Kaposi's sarcoma","volume":"13","author":"Bower","year":"1999","journal-title":"AIDS"},{"key":"10.1016\/j.jaad.2004.11.060_bib212","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1097\/00002030-200201250-00029","article-title":"Complete remission of AIDS\/Kaposi's sarcoma after treatment with a combination of two nucleoside reverse transcriptase inhibitors and one non-nucleoside reverse transcriptase inhibitor","volume":"16","author":"Murdaca","year":"2002","journal-title":"AIDS"},{"key":"10.1016\/j.jaad.2004.11.060_bib213","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/S0190-9622(98)70124-0","article-title":"Regression of Kaposi's sarcoma during therapy with HIV-1 protease inhibitors: a prospective pilot study","volume":"38","author":"Krischer","year":"1998","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2004.11.060_bib214","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1046\/j.1365-2133.1999.02818.x","article-title":"The influence of highly active antiretroviral therapy on AIDS-associated Kaposi's sarcoma","volume":"140","author":"Dupin","year":"1999","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2004.11.060_bib215","first-page":"44","article-title":"Acquired immunodeficiency syndrome\u2013related Kaposi's sarcoma regression after highly active antiretroviral therapy: biologic correlates of clinical outcome","volume":"28","author":"Cattelan","year":"2001","journal-title":"J Natl Cancer Inst Monogr"},{"key":"10.1016\/j.jaad.2004.11.060_bib216","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1046\/j.0022-202x.2001.01465.x","article-title":"Virologic and immunologic parameters that predict clinical response of AIDS-associated Kaposi's sarcoma to highly active antiretroviral therapy","volume":"117","author":"Pellet","year":"2001","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2004.11.060_bib217","doi-asserted-by":"crossref","first-page":"F45","DOI":"10.1097\/00002030-199807000-00002","article-title":"Clinical and biological impact of antiretroviral therapy with protease inhibitors on HIV-related Kaposi's sarcoma","volume":"12","author":"Lebbe","year":"1998","journal-title":"AIDS"},{"key":"10.1016\/j.jaad.2004.11.060_bib218","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1097\/00126334-199910010-00017","article-title":"Development of Kaposi's sarcoma despite sustained suppression of HIV plasma viremia","volume":"22","author":"Chan","year":"1999","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.jaad.2004.11.060_bib219","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/nm0302-225","article-title":"HIV protease inhibitors are potent anti-angiogenic molecules and promote regression of Kaposi sarcoma","volume":"8","author":"Sgadari","year":"2002","journal-title":"Nat Med"},{"key":"10.1016\/j.jaad.2004.11.060_bib220","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1002\/ijc.11648","article-title":"The efficacy of ritonavir in the prevention of AIDS-related Kaposi's sarcoma","volume":"108","author":"Stebbing","year":"2004","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jaad.2004.11.060_bib221","doi-asserted-by":"crossref","first-page":"F17","DOI":"10.1097\/00002030-200307250-00001","article-title":"A comparison of regimens based on non-nucleoside reverse transcriptase inhibitors or protease inhibitors in preventing Kaposi's sarcoma","volume":"17","author":"Portsmouth","year":"2003","journal-title":"AIDS"},{"issue":"Suppl 2","key":"10.1016\/j.jaad.2004.11.060_bib222","first-page":"S3","article-title":"European guidelines for the clinical management and treatment of HIV-infected adults in Europe","volume":"17","year":"2003","journal-title":"AIDS"},{"key":"10.1016\/j.jaad.2004.11.060_bib223","doi-asserted-by":"crossref","first-page":"381","DOI":"10.7326\/0003-4819-137-5_Part_2-200209031-00001","article-title":"Guidelines for using antiretroviral agents among HIV-infected adults and adolescents","volume":"137","author":"Dybul","year":"2002","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jaad.2004.11.060_bib224","first-page":"1","article-title":"Guidelines for using antiretroviral agents among HIV-infected adults and adolescents. Recommendations of the Panel on Clinical Practices for Treatment of HIV","volume":"51","author":"Dybul","year":"2002","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.jaad.2004.11.060_bib225","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1001\/jama.292.2.251","article-title":"Treatment for adult HIV infection: 2004 recommendations of the International AIDS Society\u2013USA Panel","volume":"292","author":"Yeni","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.jaad.2004.11.060_bib226","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1097\/00002030-199812000-00009","article-title":"Kaposi's sarcoma in HIV infection: impact on opportunistic infections and survival","volume":"12","author":"Brodt","year":"1998","journal-title":"AIDS"},{"key":"10.1016\/j.jaad.2004.11.060_bib227","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1200\/JCO.1999.17.6.1876","article-title":"Paclitaxel is safe and effective in the treatment of advanced AIDS-related Kaposi's sarcoma","volume":"17","author":"Gill","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jaad.2004.11.060_bib228","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/cncr.10634","article-title":"Multicenter trial of low-dose paclitaxel in patients with advanced AIDS-related Kaposi sarcoma","volume":"95","author":"Tulpule","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/j.jaad.2004.11.060_bib229","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1200\/JCO.2000.18.7.1550","article-title":"Vinorelbine is an effective and safe drug for AIDS-related Kaposi's sarcoma: results of a phase II study","volume":"18","author":"Nasti","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jaad.2004.11.060_bib230","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1007\/s002800050556","article-title":"Vinca alkaloids and macrolides in human immunodeficiency virus\u2013related malignancies: a safe association","volume":"39","author":"Torresin","year":"1996","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.jaad.2004.11.060_bib231","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1111\/j.1365-4362.1996.tb02990.x","article-title":"Advanced epidemic Kaposi's sarcoma: treatment with bleomycin or combination of doxorubicin, bleomycin, and vincristine","volume":"35","author":"Hernandez","year":"1996","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2004.11.060_bib232","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/0002-9343(91)90601-S","article-title":"Systemic treatment of AIDS-related Kaposi's sarcoma: results of a randomized trial","volume":"90","author":"Gill","year":"1991","journal-title":"Am J Med"},{"key":"10.1016\/j.jaad.2004.11.060_bib233","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1097\/00000421-199008000-00010","article-title":"Treatment of advanced Kaposi's sarcoma using a combination of bleomycin and vincristine","volume":"13","author":"Gill","year":"1990","journal-title":"Am J Clin Oncol"},{"issue":"Suppl 1","key":"10.1016\/j.jaad.2004.11.060_bib234","doi-asserted-by":"crossref","first-page":"S40","DOI":"10.1097\/00000421-199112001-00008","article-title":"GM-CSF as an alternative to dose modification of the combination zidovudine and interferon-alpha in the treatment of AIDS-associated Kaposi's sarcoma","volume":"14","author":"Scadden","year":"1991","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.jaad.2004.11.060_bib235","first-page":"278","article-title":"AIDS Clinical Trials Group Study 094: a phase I\/II trial of ABV chemotherapy with zidovudine and recombinant human GM-CSF in AIDS-related Kaposi's sarcoma","volume":"3","author":"Gill","year":"1997","journal-title":"Cancer J Sci Am"},{"key":"10.1016\/j.jaad.2004.11.060_bib236","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1200\/JCO.1998.16.2.683","article-title":"Randomized comparative trial of pegylated liposomal doxorubicin versus bleomycin and vincristine in the treatment of AIDS-related Kaposi's sarcoma. International Pegylated Liposomal Doxorubicin Study Group","volume":"16","author":"Stewart","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jaad.2004.11.060_bib237","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1200\/JCO.1996.14.8.2353","article-title":"Randomized phase III trial of liposomal daunorubicin versus doxorubicin, bleomycin, and vincristine in AIDS-related Kaposi's sarcoma","volume":"14","author":"Gill","year":"1996","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jaad.2004.11.060_bib238","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S0936-6555(05)80088-3","article-title":"Liposomal daunorubicin in advanced Kaposi's sarcoma: a phase II study","volume":"5","author":"Money-Kyrle","year":"1993","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1016\/j.jaad.2004.11.060_bib239","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1007\/s11912-001-0016-5","article-title":"Liposomal encapsulated anthracyclines: new therapeutic horizons","volume":"3","author":"Muggia","year":"2001","journal-title":"Curr Oncol Rep"},{"key":"10.1016\/j.jaad.2004.11.060_bib240","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1310\/700B-9QT3-HGN9-Q3FQ","article-title":"Response to liposomal doxorubicin and clinical outcome of HIV-1-infected patients with Kaposi's sarcoma receiving highly active antiretroviral therapy","volume":"2","author":"Nunez","year":"2001","journal-title":"HIV Clin Trials"},{"key":"10.1016\/j.jaad.2004.11.060_bib241","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/0140-6736(93)91624-U","article-title":"Liposomal doxorubicin in AIDS-related Kaposi's sarcoma","volume":"342","author":"Hengge","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.jaad.2004.11.060_bib242","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1046\/j.1365-2133.1998.02422.x","article-title":"Progressive HHV-8-positive classic Kaposi's sarcoma: rapid response to interferon alpha-2a but persistence of HHV-8 DNA sequences in lesional skin","volume":"139","author":"Pfrommer","year":"1998","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2004.11.060_bib243","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1097\/00001622-200109000-00010","article-title":"Management of Kaposi sarcoma: the role of interferon and thalidomide","volume":"13","author":"Krown","year":"2001","journal-title":"Curr Opin Oncol"},{"key":"10.1016\/j.jaad.2004.11.060_bib244","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1056\/NEJM198310133091512","article-title":"Interferon in the treatment of Kaposi's sarcoma","volume":"309","author":"Kondlapoodi","year":"1983","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2004.11.060_bib245","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1093\/clinids\/23.3.501","article-title":"Regression of AIDS-related Kaposi's sarcoma during therapy with thalidomide","volume":"23","author":"Soler","year":"1996","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jaad.2004.11.060_bib246","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1200\/JCO.2000.18.13.2593","article-title":"Activity of thalidomide in AIDS-related Kaposi's sarcoma","volume":"18","author":"Little","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jaad.2004.11.060_bib247","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1097\/00002030-199816000-00012","article-title":"Treatment of early AIDS-related Kaposi's sarcoma with oral all-trans-retinoic acid: results of a sequential non-randomized phase II trial. Kaposi's Sarcoma ANRS Study Group. Agence Nationale de Recherches sur le SIDA","volume":"12","author":"Saiag","year":"1998","journal-title":"AIDS"},{"issue":"Suppl 3","key":"10.1016\/j.jaad.2004.11.060_bib248","first-page":"S26","article-title":"All-trans retinoic acid for the treatment of AIDS-related Kaposi's sarcoma: results of a pilot phase II study","volume":"8","author":"Gill","year":"1994","journal-title":"Leukemia"},{"key":"10.1016\/j.jaad.2004.11.060_bib249","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1159\/000063378","article-title":"Treatment of Kaposi's sarcoma with human chorionic gonadotropin","volume":"204","author":"Simonart","year":"2002","journal-title":"Dermatology"},{"key":"10.1016\/j.jaad.2004.11.060_bib250","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1001\/archderm.137.9.1149","article-title":"Treatment of Kaposi sarcoma with oral administration of shark cartilage in a human herpesvirus 8\u2013seropositive, human immunodeficiency virus\u2013seronegative homosexual man","volume":"137","author":"Hillman","year":"2001","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2004.11.060_bib251","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/S0889-8588(03)00043-1","article-title":"Clinical presentations and standard therapy of AIDS-associated Kaposi's sarcoma","volume":"17","author":"Von Roenn","year":"2003","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1016\/j.jaad.2004.11.060_bib252","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1016\/0360-3016(91)90327-Z","article-title":"Radiotherapy in the management of cutaneous epidemic Kaposi's sarcoma","volume":"21","author":"Geara","year":"1991","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.jaad.2004.11.060_bib253","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1001\/jama.1984.03350070052024","article-title":"Initial observations of the effect of radiotherapy on epidemic Kaposi's sarcoma","volume":"252","author":"Cooper","year":"1984","journal-title":"JAMA"},{"key":"10.1016\/j.jaad.2004.11.060_bib254","first-page":"342","article-title":"Total skin electron treatment of extensive cutaneous lesions in Kaposi sarcoma","volume":"43","author":"Margaretic","year":"2002","journal-title":"Croat Med J"},{"key":"10.1016\/j.jaad.2004.11.060_bib255","first-page":"260","article-title":"Photodynamic therapy improves Kaposi's sarcoma in AIDS patients","volume":"38","author":"Schweitzer","year":"1988","journal-title":"Am Fam Physician"},{"key":"10.1016\/j.jaad.2004.11.060_bib256","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1097\/00002030-199909100-00013","article-title":"Photofrin photodynamic therapy for treatment of AIDS-related cutaneous Kaposi's sarcoma","volume":"13","author":"Bernstein","year":"1999","journal-title":"AIDS"},{"key":"10.1016\/j.jaad.2004.11.060_bib257","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1097\/00126334-199109000-00002","article-title":"Cryotherapy for cutaneous Kaposi's sarcoma (KS) associated with acquired immune deficiency syndrome (AIDS): a phase II trial","volume":"4","author":"Tappero","year":"1991","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.jaad.2004.11.060_bib258","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0385-8146(00)00053-5","article-title":"Local treatment of AIDS-associated bulky Kaposi's sarcoma in the head and neck region","volume":"27","author":"Shimomura","year":"2000","journal-title":"Auris Nasus Larynx"},{"key":"10.1016\/j.jaad.2004.11.060_bib259","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1159\/000249591","article-title":"Intralesional chemotherapy for Kaposi's sarcoma","volume":"169","author":"Brambilla","year":"1984","journal-title":"Dermatologica"},{"key":"10.1016\/j.jaad.2004.11.060_bib260","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/S0140-6736(89)91114-8","article-title":"Intralesional vinblastine for oral Kaposi sarcoma in HIV infection","volume":"2","author":"Epstein","year":"1989","journal-title":"Lancet"},{"key":"10.1016\/j.jaad.2004.11.060_bib261","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/0190-9622(93)70010-Q","article-title":"Intralesional vinblastine for cutaneous Kaposi's sarcoma associated with acquired immunodeficiency syndrome. A clinical trial to evaluate efficacy and discomfort associated with infection","volume":"28","author":"Boudreaux","year":"1993","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2004.11.060_bib262","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1002\/1097-0142(19930301)71:5<1722::AID-CNCR2820710503>3.0.CO;2-0","article-title":"Treatment of oral Kaposi sarcoma with intralesional vinblastine","volume":"71","author":"Epstein","year":"1993","journal-title":"Cancer"},{"key":"10.1016\/j.jaad.2004.11.060_bib263","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1346-8138.1992.tb03176.x","article-title":"Intralesional human leukocyte interferon treatment alone or associated with IL-2 in non-AIDS related Kaposi's sarcoma","volume":"19","author":"Ghyka","year":"1992","journal-title":"J Dermatol"},{"key":"10.1016\/j.jaad.2004.11.060_bib264","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/0190-9622(93)70139-K","article-title":"Intralesional interferon-alpha and zidovudine in epidemic Kaposi's sarcoma","volume":"28","author":"Dupuy","year":"1993","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2004.11.060_bib265","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1056\/NEJM199610243351702","article-title":"The effects of preparations of human chorionic gonadotropin on AIDS-related Kaposi's sarcoma","volume":"335","author":"Gill","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2004.11.060_bib266","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1097\/00042560-199911010-00004","article-title":"Treatment of AIDS-related cutaneous Kaposi's sarcoma with topical alitretinoin (9-cis-retinoic acid) gel. Panretin Gel North American Study Group","volume":"22","author":"Walmsley","year":"1999","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.jaad.2004.11.060_bib267","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1086\/375230","article-title":"Human herpesvirus 8: current issues","volume":"37","author":"Cannon","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jaad.2004.11.060_bib268","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1056\/NEJM199904083401402","article-title":"Oral ganciclovir for patients with cytomegalovirus retinitis treated with a ganciclovir implant. Roche Ganciclovir Study Group","volume":"340","author":"Martin","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2004.11.060_bib269","first-page":"1101","article-title":"Anti-herpesvirus treatment and risk of Kaposi's sarcoma in HIV infection. Royal Free\/Chelsea and Westminster Hospitals Collaborative Group","volume":"10","author":"Mocroft","year":"1996","journal-title":"AIDS"},{"key":"10.1016\/j.jaad.2004.11.060_bib270","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1093\/infdis\/173.6.1477","article-title":"Use of antiherpes drugs and the risk of Kaposi's sarcoma: data from the Multicenter AIDS Cohort Study","volume":"173","author":"Glesby","year":"1996","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jaad.2004.11.060_bib271","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1056\/NEJM199606063342302","article-title":"Oral ganciclovir for the prevention of cytomegalovirus disease in persons with AIDS. Roche Cooperative Oral Ganciclovir Study Group","volume":"334","author":"Spector","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2004.11.060_bib272","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1097\/00042560-199901010-00005","article-title":"Effect of antiviral drugs used to treat cytomegalovirus end-organ disease on subsequent course of previously diagnosed Kaposi's sarcoma in patients with AIDS","volume":"20","author":"Robles","year":"1999","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"key":"10.1016\/j.jaad.2004.11.060_bib273","doi-asserted-by":"crossref","first-page":"749","DOI":"10.3109\/00365549409008645","article-title":"Long-term remission of Kaposi's sarcoma following foscarnet treatment in HIV-infected patients","volume":"26","author":"Morfeldt","year":"1994","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.jaad.2004.11.060_bib274","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/S0889-8588(03)00042-X","article-title":"Therapy of AIDS-associated Kaposi's sarcoma: targeting pathogenetic mechanisms","volume":"17","author":"Krown","year":"2003","journal-title":"Hematol Oncol Clin North Am"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962204039593?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962204039593?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T21:39:31Z","timestamp":1759268371000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962204039593"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,2]]},"references-count":274,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,2]]}},"alternative-id":["S0190962204039593"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2004.11.060","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2006,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cutaneous malignancy and human immunodeficiency virus disease","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2004.11.060","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}